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The Eph family receptor-interacting (ephrin) ligands and erythropoietin-producing
hepatocellular carcinoma (Eph) receptors constitute the largest known family of receptor
tyrosine kinases. Ephrin ligands and their receptors form an important cell communication
system with widespread roles in normal physiology and disease pathogenesis. In order
to investigate potential roles of the ephrin-Eph system during palatogenesis and tongue
development, we have characterized the cellular mRNA expression of family members
EphrinA1-A3, EphA1–A8, and EphrinB2, EphB1, EphB4 during murine embryogenesis
between embryonic day 13.5–16.5 using radioactive in situ hybridization. With the
exception of EphA6 and ephrinA3, all genes were regionally expressed during the
process of palatogenesis, with restricted and often overlapping domains. Transcripts
were identified in the palate epithelium, localized at the tip of the palatal shelves,
in the mesenchyme and also confined to the medial epithelium seam. Numerous
Eph transcripts were also identified during tongue development. In particular, EphA1
and EphA2 demonstrated a highly restricted and specific expression in the tongue
epithelium at all stages examined, whereas EphA3 was strongly expressed in the lateral
tongue mesenchyme. These results suggest regulatory roles for ephrin-EphA signaling
in development of the murine palate and tongue.
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INTRODUCTION
The formation of a palate separating the oral and nasal cavities is a developmental process
characteristic of higher vertebrates and requires complex and highly coordinated molecular
interactions (reviewed in Ferguson, 1988; Cobourne, 2004; Dudas et al., 2007; Gritli-Linde, 2007).
In the embryo, the primary palate is a derivative of the frontonasal process, whilst the secondary
palate forms from the paired palatal shelves of the maxillary process, themselves a derivative of
the first pharyngeal arch. The palate is formed by elevation and fusion of the maxillary palatal
shelves, with each other posteriorly, with the primary palate anteriorly and the nasal septum
superiorly (reviewed in Dudas et al., 2007). The palatal structures are built from cranial neural
crest (CNC)-derived ectomesenchyme, mesoderm and the oro-pharyngeal ectoderm (reviewed in
Ferguson, 1988). In mice, the palate is formed relatively late in organogenesis, with the palatal
shelves initially appearing at embryonic day (E) 11.5 and growing vertically adjacent to the
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developing tongue from E12.5 to E14.0. However, by
E14.5 the shelves have elevated above the tongue and
grown to meet their counterpart at the midline, where
the layers of epithelium adhere and then fuse with each
other to achieve continuity in the roof of the oral cavity
(Figures 1A–L).
Palatal shelf elevation is a rapid process, accompanied
and facilitated by changes within the extracellular matrix of
the palatal shelf mesenchyme and the coordinated movement
of other craniofacial structures. It is generally accepted that
elevation of the palatal shelves above the tongue and their
associated change in orientation from a vertical to horizontal
FIGURE 1 | Frontal sections through the developing craniofacial region of the early mouse embryo between E13.5 and E16.5. At E13.5, the palatal shelves
are positioned vertically adjacent to the developing tongue. At E14.5 the shelves have elevated above the tongue and grown to meet their counterpart at the midline,
where the layers of epithelium adhere and begin to fuse with each other. At E15.5, continuity has been achieved and the palate separates the oral and nasal cavities.
At E16.5, palatogenesis is essentially complete. g, genioglossus; hf, hair follicle; itb, incisor tooth bud; Mc, Meckel’s cartilage; mes, medial epithelium seam; mtb molar
tooth bud; nc, nasal cavity; ns, nasal septum; pb, presphenoid bone; ps, palatal shelves; sm, submandibular gland; t, tongue. Scale bar in L = 500µm for (A–L).
position, arises from a combination of intrinsic and extrinsic
forces, including descent of the tongue (Ferguson, 1988). The
complexity of palatogenesis means that in humans it is frequently
disturbed, resulting in the birth defect of cleft palate (reviewed in
Ferguson, 1988; Cobourne, 2004). The causes of cleft palate as
a malformation can be broadly categorized on an embryological
basis as a lack of adequate growth in the palatal shelves,
failure to elevate above the tongue or a breakdown in the
mechanism of fusion between the shelves. In addition, cleft palate
can also arise secondary to other craniofacial malformations,
such as micrognathia and basoccipital or basisphenoid fusion,
craniosynostosis and both muscle and tongue abnormalities
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(reviewed in Ferguson, 1988; Rice et al., 2004; Casey et al.,
2006; Chai and Maxson, 2006; Gritli-Linde, 2007; Xiong et al.,
2009).
Development of the vertebrate tongue involves contributions
from CNC cells derived from pharyngeal arches 1–3 and the
somitic myoblasts (Parada and Chai, 2015). The oral portion or
anterior two thirds of the murine tongue emerges from the floor
of the early oral cavity as a set of mesenchymal swellings derived
from the first branchial arch. A medial lingual swelling initially
forms, but this is rapidly engulfed by two lateral lingual swellings
that will form the anterior two thirds proper. The posterior third
or pharyngeal component is derived from two further swellings
within the third branchial arch, the copula and hypopharyngeal
eminence (Noden and Francis-West, 2006; Hosokawa et al.,
2010). In the mouse embryo, the process of tongue development
begins around E10.5, with a noticeable tongue bud evident by
E12.5, which undergoes rapid enlargement and differentiation
to form a large muscular organ by E16.5 (Parada et al., 2012;
Figures 1A–L).
The Eph family receptor-interacting (ephrin) ligands and
erythropoietin-producing hepatocellular carcinoma (Eph)
receptors have been extensively studied since their discovery
(Hirai et al., 1987). Ephs constitute the largest known family
of receptor tyrosine kinases, comprising at least 16 distinct
receptors that are highly conserved (Hirai et al., 1987; Jones
et al., 1995; Scales et al., 1995; Lackmann and Boyd, 2008;
Islam et al., 2010). Based on structural features in their ligand-
binding domains and their ephrin-binding preferences, Ephs
are classified into 10 EphA and 6 EphB receptors. The EphA
group preferentially bind glycosylphosphatidylinositol (GPI)-
linked ligands of the ephrin-A subclass; whilst the EphB group
preferentially interact with transmembrane ligands of the
ephrin-B subclass (reviewed in Lackmann and Boyd, 2008).
However, EphA4 binds both classes of ephrin and EphB2 can
bind ephrinA5 (Himanen et al., 2004; Dravis and Henkemeyer,
2011).
Together, Eph receptors and their ligands, form an important
cell communication system with widespread roles in normal
physiology and disease pathogenesis (Pasquale, 2005, 2010).
Eph–ephrin complexes emanate bidirectional signals, forward
signals that depend on Eph kinase activity propagated in the
receptor-expressing cell and reverse signals, that depend on Src
family kinases propagated in the ephrin-expressing cell. Ephrin-
dependent but kinase-independent Eph signals can also occur
(Gu and Park, 2001; Matsuoka et al., 2005; Miao et al., 2005).
Eph signaling is known to control cell morphology, adhesion,
migration, and invasion by modifying organization of the actin
cytoskeleton and influencing the activities of integrins and
intercellular adhesion molecules (Pasquale, 2005, 2010; Klein,
2012).
There is evidence from both humans and mice for the
potential involvement of specific ephrin and Eph family members
during palate development. In the human craniofrontonasal
syndrome, mutations in EPHRINB1 give rise to a range of
cranial defects, including cleft lip and palate (Twigg et al., 2004;
Wieland et al., 2004; Torii et al., 2007); whilst targeted disruption
of EphrinB1 in mice results in craniofacial and other skeletal
defects, including cleft palate (Orioli et al., 1996; Compagni et al.,
2003; Davy et al., 2004). Additionally, engineering of compound
transgenic mice for EphB2 and EphB3 leads to cleft palate;
suggesting that a combination of EphB3 protein and EphB2
forward signaling is important for palate development (Risley
et al., 2009).
EphA-family receptor expression patterns have previously
been described in the developing palate (Agrawal et al., 2014);
however, only limited tongue expression data was shown. On
the basis of this previous data and a rudimentary PCR-based
screen of EphA transcriptional activity in the developing palate
(data not shown) we have investigated expression of EphA-family
members and their ephrin-A ligands during murine palate and
tongue development. We also mapped ephrinb2 expression in
these regions, given that this ligand interacts with EphA4, and
ephrinB2 reverse signaling is known to be important for normal
closure of the secondary palate (Dravis and Henkemeyer, 2011).
In addition, EphB1 and EphB4 expression was analyzed. EphB1
has also been associated with cleft lip and palate in human
populations (Watanabe et al., 2006) and previously identified as
the preferred receptor of ephrinB2 in the mechanism of axonal
pathfinding (Chenaux and Henkemeyer, 2011); whilst EphB4
only binds ephrinB2 amongst all the ephrin-B family ligands
(Sakano et al., 1996).
We find widespread expression of these family members
during murine palatogenesis. In addition, regionally-restricted
expression of many members in the developing tongue, suggests
some commonalities during the coordinated development of the
palate and tongue.
MATERIALS AND METHODS
Mouse plasmids containing cDNA were linearized with the
appropriate restriction enzymes and antisense 35S-UTP radio-
labeled riboprobes generated using specific RNA polymerases
(Table 1).
CD-1 mice were time-mated and pregnant females sacrificed
with cervical dislocation. Matings were set up such that noon of
the day on which vaginal plugs were detected was considered as
E0.5. Embryos were collected between E13.5 and E16.5, fixed in
4% (w/v) paraformaldehyde at 4◦C overnight, washed in PBS,
dehydrated through a graded series of ethanols, embedded in
paraffin wax and sectioned at 7µm, prior to section in situ
hybridisation.
Radioactive section in situ hybridisation was carried out as
previously described (Xavier et al., 2009). Light and dark-field
images of sections were photographed using a Zeiss Axioscop
microscope and merged in Adobe Photoshop CS2.
RESULTS AND DISCUSSION
EphrinA1 transcripts were identified in the palate epithelium
from E13.5 to E16.5 (Figures 2A–D), particularly at the tip
of the palatal shelf at E13.5 (Figure 2A, highlighted) with
strong expression throughout the oral surface of the palatal
shelf epithelium at E14.5 (Figure 2B, highlighted). In contrast,
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TABLE 1 | Plasmids used for the generation of riboprobes.
Gene Source Sequence length Restriction enzyme Polymerase
ephrinA1 David Wilkinson 1.5 kb SalI T3
ephrinA2 David Wilkinson 1.6 kb HindIII T3
ephrinA3 David Wilkinson 1.2 kb NotI T7
EphA1 RZPD-IMAGE 4196138 3.2 kb—Full length EcorV T7
EphA2 David Wilkinson 1.3 kb—3′ coding HindIII T7
EphA3 Tyler Cutforth 1.7 kb—extracell dom XBaI T3
EphA4 David Wilkinson 1.5 kb—3′UTR HindIII T7
EphA5 Andrea Ballabio 0.6 kb—3′UTR EcoRI T3
EphA6 David Feldheim 4.4 kb BamHI T7
EphA7 RZPD-IMAGE 3991628 3.5 kb—Full length EcoRV T7
EphA8 Tyler Cutforth 0.5 kb EcorV T3
ephrinB2 Andrea Ballabio 1 kb—Full length ORF NotI T3
EphB1 Mark Henkemeyer 0.6 kb—Exon 3 SacII SP6
EphB4 David Anderson 1 kb—kinase frag EcoRI T7
FIGURE 2 | EphrinA1, EphrinA2, and EphrinA3 expression in the craniofacial region of the mouse embryo between E13.5 and E16.5. Radioactive in situ
hybridization of frontal sections of embryos. Regions of EphrinA1 and EphrinA2 expression in the palatal shelf are highlighted at E13.5 and E14.5, respectively in (A, E)
and (B, F) for each gene. At E13.5, EphrinA1 expression was intensified in epithelium at the tip of the palatal shelf (arrow in A), and strongly expressed throughout the
epithelium at E14.5 (arrow in B). EphrinA2 was localized to the medial epithelial seam of the palate during fusion of the shelves at E14.5 (arrow in F). EphrinA3
expression was confined to epithelium of the developing nasal cavity and vomeronasal organ as shown in sections (I–L). mtg, molar tooth germ; nc, nasal cavity; nce,
nasal cavity epithelium; ns, nasal septum; ps, palatal shelves; t, tongue; vno, vomeronasal organ. Scale bar in L = 500µm for (A–L).
EphrinA1 was only expressed at background levels between
E13.5 and E16.5 (Figures 2A–D). EphrinA2 showed no specific
epithelial expression in the palate at E13.5, although transcripts
were present in the mesenchyme (Figure 2E, highlighted);
however, by E14.5 distinct transcriptional activity was observed
in the MES (Figure 2F, highlighted). During subsequent
development at E15.5–E16.5 EphrinA2 upregulated in the palatal
shelf epithelium (Figures 2G,H). EphrinA3 was not detected
above low-level background signal in the developing palate
between E13.5 and E16.5 (data not shown). However, at E13.5
transcripts were identified in epithelium of the developing
vomeronasal organ and nasal cavity (Figure 2I), expression
domains that were maintained between E14.5 and E16.5
(Figures 2J–L).
EphA1 was generally expressed in the palatal shelf
mesenchyme at E13.5, and in a complementary manner to
its ligand EphrinA1 (see Figure 2A), was upregulated in
mesenchyme at the tip of the shelves (Figure 3A, highlighted).
Lower-level expression was maintained in the palatal
mesenchyme at later stages (Figures 3B–D), but at E15.5–E16.5
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FIGURE 3 | EphA1, EphA2, EphA3, and EphA4 expression in the craniofacial region of the mouse embryo between E13.5 and E16.5. Radioactive in situ
hybridization of frontal sections of embryos. Regions of EphA1 and EphA3 expression are highlighted at E13.5 and E14.5 in (A,J), respectively. At E13.5, EphA1
expression was intensified in mesenchyme at the tip of the palatal shelf (arrows in A). EphA3 expression was localized to regions of the epithelium and a broad region
of epithelium and mesenchyme across the midline of the palate during fusion at E14.5 (arrow and arrowhead in J, respectively). EphA4 expression was strong in the
palatal shelves prior to elevation (M), and localized to the oral epithelium and MES at later stages (N–P). mtb, molar tooth bud; ps, palatal shelves; t, tongue. Scale bar
in P = 500µm for (A–P).
EphA1 was clearly upregulated in the oral epithelium after
palatal shelf fusion (Figures 3C,D). In contrast, no expression
was detected in epithelium of the MES (Figure 3B), which is
in agreement with previous findings (Agrawal et al., 2014).
EphA2 was detected in the palatal shelf epithelium from E13.5–
E16.5 (Figures 3E–H); although no transcriptional activity
was observed in the MES (Figure 3F). EphA2 has been shown
to function as a positive regulator of mammary epithelial
proliferation and branching (Vaught et al., 2009; Park J. E.
et al., 2013) and it is known that growth of the palatal shelves
is controlled by reciprocal epithelial-mesenchymal interactions
along the antero-posterior axis (Bush and Jiang, 2012; Economou
et al., 2013). Based on the distinctive expression pattern within
the epithelium, EphA2 may be important for normal growth of
the early palatal shelves.
EphA3 was intensely expressed throughout the palatal shelves
at E13.5 (Figure 3I), although this expression became localized to
regions of epithelium at E14.5 (Figure 3J, highlighted) in contrast
to previous observations, transcripts were also detected in the
midline during the process of fusion, including the MES and
regions of adjacent mesenchyme (Figure 3J, arrowhead). EphA3
remained enriched in these regions of the palate epithelium
and mesenchyme during subsequent stages of palatogenesis
between E15.5 and E16.5 (Figures 3K,L; Agrawal et al., 2014).
EphA4 was also strongly expressed throughout the palatal shelves
prior to elevation at E13.5 (Figure 3M), progressively localizing
to the oral epithelium and MES during later development
(Figures 3N–P). Despite this dynamic expression pattern, an
absence of both EphA3 and EphA4 function does not result in
any overt developmental phenotype in the mouse, including the
palate. Redundant roles played by other family members may
explain the lack of palate phenotype in compound EphA3−/−;
EphA4−/− mutant embryos (Agrawal et al., 2014). EphA5
hybridization signals were present in a patchy distribution within
the mesenchymal component of the palatal shelves at E13.5,
(Figure 4A, highlight); whilst during later stages, expression
was detected throughout the epithelium and very strongly
in mesenchyme at the lateral edges of the palate, with this
strong expression also observed in the nasal cavity epithelium
(Figure 4B). Following fusion at E15.5, EphA5 was localized to
the palatal epithelium (Figure 4C, arrowed); however, at E16.5,
marked up-regulation was observed in the mesenchyme, but
restricted to medial regions of the fused shelves (Figure 4D).
EphA6 transcripts were not detected at any significant level
in the palatal shelves at E13.5 (data not shown) although
some upregulation was seen in mesenchyme of the nasal cavity
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FIGURE 4 | EphA5, EphA6, EphA7, and EphA8 expression in the craniofacial region of the mouse embryo between E13.5 and E16.5. Radioactive in situ
hybridization of frontal sections of embryos. Regions of EphA5 and EphA7 expression are highlighted at E13.5 and E15.5 in (A,K), respectively. At E13.5, there was
patchy expression of EphA5 in the palatal shelf mesenchyme (arrow in A), whilst at E15.5, expression was detected in the palatal shelf epithelium (arrow in C). EphA6
expression was confined to mesenchyme of the developing nasal cavity at E13.5 (arrowheads in E) but upregulated in oral epithelium at E15.5 (arrows in G). EphA7
was strongly expressed in the epithelium throughout palatogenesis, but was upregulated in the palatal midline at E15.5 (arrow and arrowhead in K, respectively).
EphA8 was also strongly expressed in the mid-palatal region at E15.5 (arrowhead in O). le, lens; mtb, molar tooth bud; nce, nasal cavity epithelium; nlr, neural layer of
the retina; oe, oral epithelium; ps, palatal shelves; t, tongue; tg, trigeminal ganglion. Scale bar in P = 500µm for (A–P).
(Figure 4E, arrowheads). Transcripts were detected in palatal
epithelium of the oral cavity during fusion at E14.5, but they
were absent from the MES (Figure 4F) and no expression
was observed following fusion of the palatal shelves at E15.5
(Figure 4G) and E16.5 (data not shown). Interestingly, there
was strong localized expression of EphA6 in epithelium of the
oral commissure at E15.5 (Figure 4G, arrowed) and intense
expression also identified in the lens and neural layer of the
retina at E16.5 (Figure 4H). EphA7 was consistently detected
in the palatal shelf epithelium throughout palatogenesis, but
only weakly in the mesenchyme (Figures 4I–L, highlight in
Figure 4K). However, at E15.5 strong midline expression was
detected (Figure 4K, arrowhead). This expression pattern was
different from that described in previously published data, where
EphA7 was mainly observed in the mesenchyme (Agrawal et al.,
2014). EphA8 showed intense expression in both the epithelium
andmesenchyme of the palatal shelves at E13.5 (Figure 4M), with
lower-level expression at later stages; again, with the exception
at E15.5, where strong expression was detected in the midline
mesenchymal region (Figures 4N–P, arrowhead in Figure 4O),
which also differs from that previously reported (Agrawal et al.,
2014). Recently, in vivo expression of EphA8-Fc was reported
to result in neuroepithelial cell apoptosis and a subsequent
decrease in brain size (Kim et al., 2013). These findings are
in agreement with previous studies that demonstrated that
Ephrin-Eph signaling plays a critical role in determining the size
of the neuroepithelial cell population during early embryonic
brain development (Holmberg et al., 2000; Park E. et al., 2013).
EphA8may therefore have a role inmediating epithelial apoptosis
during the process of palatal shelf fusion.
EphrinB2 was expressed in the epithelium and (more
weakly) in the mesenchyme during palatogenesis, particularly
at the tip of the palatal shelves at E13.5 and in the MES
at E14.5 (Figures 5A–D, highlighted in Figure 5A). EphB1
transcriptional activity was weak but widespread in the palatal
shelf mesenchyme at E13.5–E14.5; however, by E15.5 expression
was up-regulated in the midline of the embryonic palate,
returning to previous levels by E16.5 (Figures 5E–H). EphB4
was also weakly expressed in the palatal shelf mesenchyme
throughout palatogenesis, but with strong midline expression
at E14.5 in the MES during shelf fusion (Figures 5I–L, arrow
in Figure 5J). EphB1 expression has been previously reported
in the venous vasculature throughout embryonic development
to adulthood (Li and Mukouyama, 2013). Additionally, EphB1
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FIGURE 5 | EphrinB2, EphB1, EphB4 expression in the craniofacial region of the mouse embryo between E13.5 and E16.5. Radioactive in situ
hybridization of frontal sections of embryos. EphrinB2 expression is highlighted in A (arrowed). di, diencephalon; mes, medial epithelium seam; mtb, molar tooth bud;
nce, nasal cavity epithelium; ps, palatal shelves; t, tongue; tg, trigeminal ganglion. Scale bar in D = 500µm for (A–L).
FIGURE 6 | The main domains of expression associated with the EphA family of receptors in the developing tongue at (A) E13.5 and (B) E14.5.
Diagrams not drawn to scale.
has been observed in the mouse retina (Birgbauer et al., 2000),
during the early stages of embryonic rat spinal cord development
(Jevince et al., 2006) and in the basal ganglia nuclei (Richards
et al., 2007). Interestingly, behavioral evaluation of EphB1 null
mice in an open-field environment has revealed the presence
of spontaneous locomotor hyperactivity (Richards et al., 2007).
During palatogenesis streams of directional cell migration (both
in the anterior and posterior aspect) have been demonstrated to
occur and are thought to be of importance for palate patterning
(shaping) and elevation (He et al., 2008). Interestingly, a
cellular migration system solely dependent on EphrinB2–EphB4
signal transduction has demonstrated that EphB4 is capable of
triggering the regulation of cell migration (Sturz et al., 2004).
Taken together, these results suggest that these genes could also
be involved in cell migration events that take place during palate
development.
Frontiers in Physiology | www.frontiersin.org 7 February 2016 | Volume 7 | Article 60
Xavier et al. Ephrin/Eph Expression in Palate and Tongue
FIGURE 7 | The main domains of expression associated with ephrins and Eph receptors in the developing palate at (A) E13.5 and (B) E14.5. Diagrams
not drawn to scale.
We also identified the expression of numerous Ephs during
murine tongue development between E13.5 and E16.5. The main
domains of expression associated with the EphA group in the
tongue at E13.5 and E14.5 are summarized in Figures 6A,B.
EphA5 and EphA7 presented with ubiquitous expression at E14.5
(see Figures 4B,J, respectively). During all stages examined,
EphA1 and EphA2 demonstrated distinctive expression in the
tongue epithelium (Figures 3A–H), whereas EphA3 was strongly
expressed in the lateral tongue mesenchyme between E13.5 and
E16.5 (Figures 3I–L). Although EphA4 was also detected in the
lateral tongue mesenchyme at earlier stages (Figures 3M,N); by
E15.5, transcriptional activity was down-regulated (Figure 3O)
and restricted to patchy regions of the epithelium (Figure 3O),
although at E16.5, expression was increased in the mesenchyme
(Figure 3P). EphA6 presented weak and widespread expression
in the mesenchyme during tongue development (Figures 3E–G).
However, at E14.5, a marked upregulation was observed in the
inter-molar eminence of the tongue (Figure 4F). Similarly to
EphA3, EphA7, and EphA8 transcriptional activity were also
markedly increased in the lateral mesenchyme of the tongue
during development (Figures 4I–O). However, by E16.5 EphA8
expression was down-regulated and more restricted to the
epithelial compartment (Figure 4P). Rapid depression of the
tongue in embryogenesis is critical for proper palatogenesis. Any
delay in this process can disturb palatal shelf elevation and hence,
lead to cleft palate (Nie, 2005). For these events to take place
a coordinated balance between apoptosis and proliferation is
essential (Parada et al., 2012; Parada and Chai, 2015).
The Eph and ephrin family-member gene expression in the
developing palate and tongue described here is summarized
in Figures 6, 7. These dynamic domains suggest important
potential roles for these molecules in both epithelium and
mesenchyme during development of these regions. Further
analysis using animal models will be required to delineate
the precise requirements during these developmental processes.
However, the co-expression of EphA3, A4, and A8 in the palatal
shelvesmakes it difficult to test the hypothesis that these genes are
involved in palatogenesis. Considering the known promiscuous
interactions between Ephs and ephrins, it is likely EphA3, A4,
andA8may also play redundant roles during palate development.
Analysis of a triple loss-of-function mouse model may be
required to definitively address this question.
CONCLUSIONS
Eph receptors A3, A4, and A8 are very strongly expressed within
palatal shelf mesenchyme during early palatogenesis and both
EphA1 and A5 are up-regulated at the shelf tip during this stage.
Eph receptors A3, A4, and A8 are also strongly expressed in
lateral regions of the tongue at these stages, suggesting some
co-ordination in the regulation of palatogenesis and tongue
development. EphA and ephrinA-family members are also
expressed in palatal shelf epithelium (EphA2, EphA7, ephrinA1)
and mesenchyme (EphA1, A3, A4, A5, A6, A8, and ephrinA2, A3)
suggesting the possibility of epithelial-mesenchymal interactions
being mediated by these proteins during development of the
palate.
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